Franchini Massimo, Veneri Dino
Servizio di Immunoematologia e Trasfusione, Azienda Ospedaliera di Verona, Verona, Italy.
Ann Hematol. 2005 Jun;84(6):347-52. doi: 10.1007/s00277-005-1006-8. Epub 2005 Mar 4.
Hereditary hemochromatosis, a very common genetic defect in the Caucasian population, is characterized by progressive tissue iron overload which leads to irreversible organ damage if it is not treated in a timely manner. Recent developments in the field of molecular medicine have radically improved the understanding of the physiopathology and diagnosis of this disease. However, transferrin saturation and serum ferritin are still the most reliable tests for identifying subjects with hereditary hemochromatosis. Therapeutic phlebotomy is the mainstay of the treatment of this disease and the life expectancy of these patients is similar to that of the normal population if phlebotomy is started before the onset of irreversible organ damage. In this review we discuss the genetics, pathophysiology, diagnosis, clinical features, and management of hereditary hemochromatosis.
遗传性血色素沉着症是白种人群中一种非常常见的基因缺陷疾病,其特征是组织铁进行性过载,如果不及时治疗,会导致不可逆的器官损伤。分子医学领域的最新进展从根本上提高了对这种疾病的生理病理学和诊断的认识。然而,转铁蛋白饱和度和血清铁蛋白仍然是识别遗传性血色素沉着症患者最可靠的检测方法。治疗性放血是这种疾病治疗的主要手段,如果在不可逆器官损伤发生之前开始放血治疗,这些患者的预期寿命与正常人群相似。在这篇综述中,我们讨论了遗传性血色素沉着症的遗传学、病理生理学、诊断、临床特征和管理。